O	0	10	Postpartum	Postpartum	NNP	B-NP
O	11	18	rubella	rubella	NN	I-NP
O	19	31	immunization	immunization	NN	I-NP
O	31	32	:	:	:	O
O	33	44	association	association	NN	B-NP
O	45	49	with	with	IN	B-PP
O	50	61	development	development	NN	B-NP
O	62	64	of	of	IN	B-PP
O	65	74	prolonged	prolonged	JJ	B-NP
O	75	84	arthritis	arthritis	NN	I-NP
O	84	85	,	,	,	O
B-Anatomical_system	86	98	neurological	neurological	JJ	B-NP
O	99	107	sequelae	sequela	NNS	I-NP
O	107	108	,	,	,	O
O	109	112	and	and	CC	O
O	113	120	chronic	chronic	JJ	B-NP
O	121	128	rubella	rubella	NN	I-NP
O	129	136	viremia	viremia	NN	I-NP
O	136	137	.	.	.	O

O	138	141	Six	Six	CD	B-NP
O	142	147	women	woman	NNS	I-NP
O	148	157	developed	develop	VBD	B-VP
O	158	165	chronic	chronic	JJ	B-NP
O	166	170	long	long	JJ	I-NP
O	170	171	-	-	HYPH	I-NP
O	171	175	term	term	NN	I-NP
O	176	187	arthropathy	arthropathy	NN	I-NP
O	188	193	after	after	IN	B-PP
O	194	204	postpartum	postpartum	NN	B-NP
O	205	217	immunization	immunization	NN	I-NP
O	218	225	against	against	IN	B-PP
O	226	233	rubella	rubella	NN	B-NP
O	233	234	.	.	.	O

O	235	238	All	All	DT	B-NP
O	239	250	individuals	individual	NNS	I-NP
O	251	260	developed	develop	VBD	B-VP
O	261	266	acute	acute	JJ	B-NP
O	267	280	polyarticular	polyarticular	JJ	I-NP
O	281	290	arthritis	arthritis	NN	I-NP
O	291	297	within	within	IN	B-PP
O	298	300	12	12	CD	B-NP
O	301	305	days	day	NNS	I-NP
O	306	308	to	to	TO	B-PP
O	309	314	three	three	CD	B-NP
O	315	320	weeks	week	NNS	I-NP
O	321	337	postimmunization	postimmunization	NN	I-NP
O	338	341	and	and	CC	O
O	342	346	have	have	VBP	B-VP
O	347	350	had	have	VBN	I-VP
O	351	361	continuing	continue	VBG	I-VP
O	362	369	chronic	chronic	JJ	B-NP
O	370	372	or	or	CC	I-NP
O	373	382	recurrent	recurrent	JJ	I-NP
O	383	393	arthralgia	arthralgia	NN	I-NP
O	394	396	or	or	CC	I-NP
O	397	406	arthritis	arthritis	NN	I-NP
O	407	410	for	for	IN	B-PP
O	411	414	two	two	CD	B-NP
O	415	417	to	to	TO	I-NP
O	418	423	seven	seven	CD	I-NP
O	424	429	years	year	NNS	I-NP
O	430	435	after	after	IN	B-PP
O	436	447	vaccination	vaccination	NN	B-NP
O	447	448	.	.	.	O

O	449	454	Acute	Acute	JJ	B-NP
B-Anatomical_system	455	467	neurological	neurological	JJ	I-NP
O	468	482	manifestations	manifestation	NNS	I-NP
O	482	483	,	,	,	O
O	484	494	consisting	consist	VBG	B-VP
O	495	497	of	of	IN	B-PP
O	498	504	carpal	carpal	JJ	B-NP
O	505	511	tunnel	tunnel	NN	I-NP
O	512	520	syndrome	syndrome	NN	I-NP
O	521	523	or	or	CC	O
O	524	532	multiple	multiple	JJ	B-NP
O	533	545	paresthesiae	paresthesiae	NN	I-NP
O	545	546	,	,	,	O
O	547	556	developed	develop	VBD	B-VP
O	557	572	postvaccination	postvaccination	NN	B-NP
O	573	575	in	in	IN	B-PP
O	576	581	three	three	CD	B-NP
O	582	587	women	woman	NNS	I-NP
O	587	588	.	.	.	O

O	589	592	Two	Two	CD	B-NP
O	593	597	have	have	VBP	B-VP
O	598	607	developed	develop	VBN	I-VP
O	608	618	continuing	continue	VBG	B-NP
O	619	625	active	active	JJ	I-NP
O	626	628	or	or	CC	I-NP
O	629	636	chronic	chronic	JJ	I-NP
O	637	646	recurrent	recurrent	JJ	I-NP
O	647	655	episodes	episode	NNS	I-NP
O	656	658	of	of	IN	B-PP
O	659	666	blurred	blurred	JJ	B-NP
O	667	673	vision	vision	NN	I-NP
O	673	674	,	,	,	O
O	675	687	paresthesiae	paresthesiae	NN	B-NP
O	687	688	,	,	,	O
O	689	692	and	and	CC	O
O	693	700	painful	painful	JJ	B-NP
B-Organism_subdivision	701	705	limb	limb	NN	I-NP
O	706	715	syndromes	syndrome	NNS	I-NP
O	716	724	together	together	RB	B-ADVP
O	725	729	with	with	IN	B-PP
O	730	739	recurrent	recurrent	JJ	B-NP
B-Multi-tissue_structure	740	745	joint	joint	JJ	I-NP
O	746	754	symptoms	symptom	NNS	I-NP
O	754	755	.	.	.	O

O	756	763	Chronic	Chronic	JJ	B-NP
O	764	771	rubella	rubella	NN	I-NP
O	772	779	viremia	viremia	NN	I-NP
O	780	783	has	have	VBZ	B-VP
O	784	788	been	be	VBN	I-VP
O	789	797	detected	detect	VBN	I-VP
O	798	800	in	in	IN	B-PP
B-Cell	801	811	peripheral	peripheral	JJ	B-NP
I-Cell	812	817	blood	blood	NN	I-NP
I-Cell	818	829	mononuclear	mononuclear	JJ	I-NP
I-Cell	830	834	cell	cell	NN	I-NP
O	835	836	(	(	(	O
B-Cell	836	839	MNC	MNC	NN	B-NP
O	839	840	)	)	)	O
O	841	852	populations	population	NNS	B-NP
O	853	855	in	in	IN	B-PP
O	856	860	five	five	CD	B-NP
O	861	863	of	of	IN	B-PP
O	864	867	the	the	DT	B-NP
O	868	871	six	six	CD	I-NP
O	872	877	women	woman	NNS	I-NP
O	878	880	up	up	RB	B-NP
O	881	883	to	to	TO	I-NP
O	884	887	six	six	CD	I-NP
O	888	893	years	year	NNS	I-NP
O	894	899	after	after	IN	B-PP
O	900	911	vaccination	vaccination	NN	B-NP
O	911	912	.	.	.	O

O	913	915	In	In	IN	B-PP
O	916	924	addition	addition	NN	B-NP
O	925	932	rubella	rubella	NN	I-NP
O	933	938	virus	virus	NN	I-NP
O	939	942	was	be	VBD	B-VP
O	943	951	isolated	isolate	VBN	I-VP
O	952	956	from	from	IN	B-PP
B-Cell	957	963	breast	breast	NN	B-NP
I-Cell	964	968	milk	milk	NN	I-NP
I-Cell	969	973	MNCs	MNC	NNS	I-NP
O	974	976	in	in	IN	B-PP
O	977	980	one	one	CD	B-NP
O	981	991	individual	individual	NN	I-NP
O	992	994	at	at	IN	B-PP
O	995	999	nine	nine	CD	B-NP
O	1000	1006	months	month	NNS	I-NP
O	1007	1022	postvaccination	postvaccination	NN	B-NP
O	1023	1026	and	and	CC	B-PP
O	1027	1031	from	from	IN	B-PP
B-Cell	1032	1042	peripheral	peripheral	JJ	B-NP
I-Cell	1043	1048	blood	blood	NN	I-NP
I-Cell	1049	1053	MNCs	MNC	NNS	I-NP
O	1054	1056	in	in	IN	B-PP
O	1057	1060	two	two	CD	B-NP
O	1061	1063	of	of	IN	I-NP
O	1064	1068	four	four	CD	I-NP
B-Organism_subdivision	1069	1075	breast	breast	NN	I-NP
O	1075	1076	-	-	HYPH	O
O	1076	1079	fed	feed	VBN	B-NP
O	1080	1087	infants	infant	NNS	I-NP
O	1088	1095	studied	study	VBN	B-VP
O	1096	1098	at	at	IN	B-PP
O	1099	1101	12	12	CD	B-NP
O	1101	1102	-	-	HYPH	I-NP
O	1102	1104	18	18	CD	I-NP
O	1105	1111	months	month	NNS	I-NP
O	1112	1114	of	of	IN	B-PP
O	1115	1118	age	age	NN	B-NP
O	1118	1119	.	.	.	O

O	1120	1126	Immune	Immune	JJ	B-NP
O	1127	1136	responses	response	NNS	I-NP
O	1137	1139	to	to	TO	B-PP
O	1140	1147	rubella	rubella	NN	B-NP
O	1148	1153	virus	virus	NN	I-NP
O	1154	1161	studied	study	VBN	B-VP
O	1162	1164	at	at	IN	B-PP
O	1165	1175	sequential	sequential	JJ	B-NP
O	1176	1185	intervals	interval	NNS	I-NP
O	1186	1191	after	after	IN	B-SBAR
O	1192	1203	vaccination	vaccination	NN	B-NP
O	1204	1214	correlated	correlate	VBD	B-VP
O	1215	1219	with	with	IN	B-PP
O	1220	1231	development	development	NN	B-NP
O	1232	1234	of	of	IN	B-PP
O	1235	1248	rheumatologic	rheumatologic	JJ	B-NP
O	1249	1252	and	and	CC	I-NP
B-Anatomical_system	1253	1265	neurological	neurological	JJ	I-NP
O	1266	1280	manifestations	manifestation	NNS	I-NP
O	1280	1281	.	.	.	O

